Delivery Order SPE2DB25D3109-SPE2DB25FPJRP

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.00, is for the delivery of the drug Wegovy 0.5 mg/0.5 ml pen in 0.5 ml quantities. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 31, 2024. The contract does not have a set-aside designation, indicating open competition. In addition to this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Wegovy 1 mg/0.5 ml pen (0.5 ml). The firm-fixed price, delivery order contract has a ceiling value of $1,264.25 and a period of performance through January 22, 2024. The contract is not designated with a set-aside. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,374.92, is a delivery order for the medication Wegovy 0.25 mg/0.5 ml pen with an ultimate completion date of October 31, 2024. The contract has a firm fixed price pricing type and is not designated with a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
This federal contract award, valued at $6,885.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the medication Wegovy 2.4 mg/0.75 ml pen 0.75 ml, with a completion date of December 5, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,718.24 firm fixed price delivery order is for the supply of the prescription drug Wegovy, a 0.5 mg/0.5 ml pen. The contract has an ultimate completion date of May 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is for the delivery of Wegovy 1 mg/0.5 ml pens with a ceiling value of $3,291.24. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 5, 2024. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and also holds an indefinite...
This federal contract award is for the delivery of the pharmaceutical product Wegovy 0.25 mg/0.5 ml pen 0.5ml to the Defense Logistics Agency (DLA). The contract, valued at $5,485.40, was awarded to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. This is a delivery order contract with a firm-fixed price pricing type. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Wegovy 0.25 mg/0.5 ml pens. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and a ceiling value of $1,097.08. The ultimate completion date for the contract is May 16, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is the prime contractor, and the contract will be...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,291.24 firm fixed-price delivery order contract is for the supply of the prescription drug Wegovy 0.25 mg/0.5 ml pen (0.5 ml). The contract has an ultimate completion date of April 25, 2023. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award of $1,097.08 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of the prescription drug Wegovy 0.5 mg/0.5 ml pen 0.5ml. This is a firm fixed-price delivery order contract with a completion date of June 18, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
  • SPE2DB25D3109
    Indefinite Delivery Contract
  • SPE2DB25D3109-SPE2DB25FPJRP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,602.39, is for the delivery of the drug Wegovy 0.25 mg/0.5 ml pen 0.5 ml. It is a firm fixed-price delivery order contract with a completion date of January 6, 2025. This contract award is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp is the prime contractor with no major subcontractors identified. The DLA is the funding agency for this contract, which supports the agency's role in providing medical products and pharmaceuticals to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 4/4/25, 9:45 AM